Back

Cardiac myosin inhibitors

5 December 2025 (14:50 - 15:00)
Organised by: Logo
Seminar Presentation Part of: Session 4 – Precision/Gene based therapy in hypertrophic cardiomyopathy OTHER Open Access ESC Cardio Genomics 2025 Council on Cardiovascular Genomics

About the speaker

Photo
Mr Pablo Garcia Pavia

Iron Gate Majadahonda University Hospital, Madrid (Spain)

3 More presentations in this session

Presentation thumbnail
Abstract: A non-canonical splicing variant in MYBPC3 leads to cryptic splicing in Hypertrophic Cardiomyopathy
Miss M. Furtado (PT)
Presentation thumbnail
Gene therapy
Professor L. Carrier (Hamburg, DE)
Slides
Presentation thumbnail
Genotype-specific pathomechanisms and treatments
Professor J. van der Velden (Amsterdam, NL)

Access the full session

Session thumbnail
Session 4 – Precision/Gene based therapy in hypertrophic cardiomyopathy

The Event

Event poster

ESC Cardio Genomics 2025

5 December 2025 14:50 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac myosin inhibitor, mavacamten, improves myocardial relaxation in mouse HFpEF model
30 April 2022
thumbnail
Congress Presentation
Cardiac myosin inhibitors use in the real world: what you need to know
30 August 2025
thumbnail
Congress Presentation
An in vivo model for cardiotoxicity of myeloid cell leukemia 1 inhibition (mcl1)
20 June 2025
thumbnail
Congress Presentation
Narrowing Beta-myosin hot spots in its association with hypertrophic cardiomyopathy
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources